About Max
This author has not written his bio yet.
But we are proud to say that Max contributed 468 entries already.
Entries by Max
Newsletter 41/2025
/in Newsletter/by MaxLAST WEEK TODAY! A summary of what was published on ProstateWarriors.com during the past week Hi fellow warriors! First of all, thank you! The target has been reached. Thanks to your donations, I can renew our subscription to Kit.com and keep sending the newsletters! This week we have a great mix of clinical and preclinical research, including […]
Scientists Develop “Velcro” Cancer Treatment That Works Across Many Tumor Types
/in Immunotherapy, Preclinical Research/by MaxResearchers at the University of California, Irvine have developed an innovative cancer immunotherapy called GlyTR, a new class of treatment that uses a “velcro-like” mechanism to target sugar molecules abundantly present on cancer cells. Their findings were published in September 2025 in the prestigious journal Cell, marking a significant advancement in cancer immunotherapy. Traditional immunotherapies […]
New Study Uncovers Mechanism Behind T-Cell Exhaustion, Offering Hope for Prostate Cancer Immunotherapy
/in Immunotherapy, Preclinical Research/by MaxA study from The Ohio State University Comprehensive Cancer Center has illuminated a critical reason why cancer immunotherapy often fails: T-cell exhaustion driven by a novel stress pathway called TexPSR (proteotoxic stress response in T-cell exhaustion). Published in the prestigious journal Nature, this discovery reveals a proteotoxic shock in exhausted T cells caused by the […]
Project Navigator
Let's try to finance it!
A new, user friendly way, to get information about current clinical trials available to prostate cancer patients.
Tags
Latest Posts
- Newsletter 44/2025 November 2, 2025
- 177Lu-PSMA-617 (Pluvicto) Combo With Sipulecel-T in Phase 1 Trial November 1, 2025
- News pre|CISION Platform: Delivering Two Complementary Therapies from One Molecule October 27, 2025
- Helicon Degraders Show a New Path in Prostate Cancer Therapy October 27, 2025
